Sociedad Americana de Hirudoterapia

Highly active fractions of the medicinal leech recombinant destabilase-lysozyme

Research article published in Biomeditsinskaia khimiia (2014)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: In vitro / laboratoryDesarrollo de fármacosFadeeva IY et al. · Biomeditsinskaia khimiia, 2014

Abstract

From the highly purified but lowly active recombinant protein Destabilas-Lysozyme (Dest-Lys) by use cation-exchange column TSK CM 3-SW chromatography, it was separated non-active fraction IV, contained 90% of protein. Fractions I, II and III, represented proteins with lysozyme and isopeptidase activities. Their lysozyme activity correlates with the activity of natural Des-Lys. The ratio of the activities in fractions I - III is such, that maximal lysozyme activity is concentrated in fraction III, isopeptidase - in fraction I. It is discussed the possibility of Dest-Lys different functions regulation is depended on the formation of protein complex forms. V rezul'tate fraktsionirovaniia vysokoochishchennogo nizkoaktivnogo rekombinantnogo belka destabilazy-lizotsima (Dest-Liz) na kationoobmennoĭ kolonke TSK CM 3-SW udalos' otdelit' neaktivnuiu fr.IV, soderzhashchuiu 90% belka, ot trekh fraktsiĭ (I, II i III), predstavliaiushchikh belki, lizotsimnaia i izopeptidaznaia aktivnosti kotorykh korreliruiut s aktivnostiami nativnogo fermenta. Odnako, sootnoshenie lizotsimnoĭ i izopeptidaznoĭ aktivnosteĭ vo fraktsiiakh I – III takovo, chto maksimal'naia lizotsimnaia aktivnost' sosredotochena vo fraktsii III, a izopeptidaznaia – vo fraktsii I. Obsuzhdaetsia vozmozhnost' reguliatsii raznykh funktsiĭ Dest-Liz v sviazi s obrazovaniem ego kompleksnykh form.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal Article
Indexed MeSH termsAnimalsCarbon-Nitrogen LyasesChromatography, Ion ExchangeEndopeptidasesFibrinolytic AgentsHirudo medicinalisKineticsMuramidaseRecombinant ProteinsSubstrate Specificity

Resumen

Highly active fractions of the medicinal leech recombinant destabilase-lysozyme.

Por qué esto importa para la hirudoterapia

This study describes chromatographic separation of recombinant destabilase-lysozyme (Dest-Lys) using a cation-exchange column, yielding three active fractions (I, II, III) with lysozyme and isopeptidase activities and one inactive fraction (IV, 90% of protein). Maximal lysozyme activity concentrated in fraction III while maximal isopeptidase activity was in fraction I, and the authors discussed whether regulation of Dest-Lys's different functions depends on formation of protein complex forms. Caveat: The abstract does not specify the source organism, describe the protein as part of a secretome, or characterize isopeptidase activity as fibrinolytic. While MeSH terms reference Hirudo medicinalis, the abstract itself does not establish a leech connection, so relevance to ASH's domain is indirect and cannot be confirmed from the abstract alone.

Citación

Highly active fractions of the medicinal leech recombinant destabilase-lysozyme

Fadeeva IY et al. · Biomeditsinskaia khimiia, 2014

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.